Research Mark Hamer on Clarivate's Highly Cited Researchers 2022 Professor Mark Hamer has been listed as one of the world's most influential researchers by Clarivate in their annual Highly Cited Researchers list for 2022. Long-lasting COVID impact on children Dr Snehal Pinto Pereira appeared on ITV News to discuss key findings from a new study in Lancet Europe about the long-lasting impacts of Covid-19 on children's health. See the clip. Clinician scientist wins prestigious urology award Dr Veeru Kasivisvanathan has been recognised by the European Association of Urology (EAU) with the Crystal Matula Award for remarkable achievements in advancing prostate cancer research. REF 2021 Highlight: Single-dose radiotherapy transforms breast cancer patient care Our clinicians have transformed breast cancer care by developing a single-dose radiotherapy treatment to be delivered in the same operation as tumour surgery. Our work3D Models of Health and DiseaseAestheticsBioengineering & Surgical TechnologyBiomaterials & Surgical ReconstructionBreast ResearchGastroenterological InterventionHead and NeckHuman Machine InteractionImplantsKidney Cancer Research (Coming soon)Materials ResearchMobility DevicesNanomedicine & Surgical TheranosticsNeuromodulationPerioperative MedicinePrecision Nano Systems & Advanced TherapyResponsive OncotherapeuticsSport & Exercise MedicineSurgical Innovation & TransplantsTumouroidsUrologyOur research departments Orthopaedics & Musculoskeletal Science This research department delivers science-driven breakthroughs in the restoration of pain-free functional mobility and high-quality independent living. Surgical Biotechnology This research department brings together scientists, academic clinicians, and researchers to develop new technologies and translate them into clinical practice. Targeted Intervention This research department brings together clinicians and scientists to develop highly targeted imaging, sensing, management, and energy-based interventions. Research services Surgical Interventional Group (Clinical Trials) SIG provides infrastructure for studies led by surgeons and interventionists within any anatomical site. It has history of managing large-scale multi-centre, multinational randomised controlled clinical trials in solid tumours. Tissue Access for Patient Benefit TAPb facilitates the access, storage, use and transfer of human organs, cells, and tissue between clinical centres within UCL and a range of institutions to help researchers access the materials they need.